Search results for: 'endpoint security industry global 2014 2025'

02 Sep 2025  |  Global  |  Technology Research

Technological Advances in Engineered Cell Therapies, Global, 2025–2029

Emerging Trends and Technologies in Engineered Cell Therapies

Infographics

×

Engineered cell therapies have become a revolutionary medical field, surpassing conventional methods such as systemic medications and prominent immunosuppression to provide long-lasting, programmable, and targeted treatments for complicated diseases. Recent technical developments in engineered cell therapies examine how the rapid growth of cell eng...

The research service aims to analyse and assess the global generics pharmaceutical market, map the key trends and dynamics shaping the industry sector and provide strategic recommendations for the success of the market participants. With several key blockbuster drugs losing patent protection and new healthcare reforms being introduced by the Govern...

05 Sep 2019  |  Global  |  Market Research

Digital Transformation of the Global Medtech Industry, Forecast to 2024

Growth Opportunities to Boost Revenue in this Slowing Industry by an Additional $240 Billion by 2024

Infographics

×

Key Issues Addressed

The medtech industry’s revenue growth is expected to gradually dip beyond 2020, from a year-on-year growth of about 5.7Percentage in 2020 to 5.3Percentage in 2024. The industry is already addressing this as well as several other challenges such as the changing device ecosystem, shifting competitive focus, and the invasion by technology companies. M...

With the growing preference for a patient-centric care delivery approach, the pharma industry follows a robust step-by-step approach towards market commercialization, with a clear understanding of the market stakeholders, segments, as well as post-launch forecasts to create seamless go-to-market strategies. To cater to the ever-evolving market land...

The pharmaceutical (pharma) industry is undergoing significant regulatory changes resulting from the European Green Deal and the Paris Agreement. These changes require pharma companies to adopt more environmentally sustainable practices. With the increasing demand for drugs globally, pharma R&D and manufacturing infrastructure has grown, leading to...

Pharmaceutical drug discovery and development processes suffer from declining success rates and a stagnant pipeline. Artificial Intelligence (AI) supported by Big Data could be a key element that can provide an effectual solution. There has been a rapid growth in the data generated within the life sciences and pharmaceutical industries. This stems ...

This deliverable provides research and analysis of the global infectious disease diagnostics market. It includes an in-depth analysis of revenue forecast by segment, drivers and restraints, and technology trends, along with the competitive factors and strategies, and key companies to watch. The global market is primarily driven by the high prevalen...

The medical device industry faces significant pricing pressures as the consumables and services segment gains traction from activities tied to installing new equipment and replacing or refurbishing capital equipment. Medical device vendors are focused on new business models to provide multi-vendor services, online parts ordering, remote servicing, ...

The laboratory information management systems (LIMS) industry in the United States and Europe is forecast to grow from 2023 to 2027 at a CAGR of 8.8% and 6.3%, respectively, driven by the increasing need for laboratory automation, regulatory compliance, and cloud-based solutions. Prominent players in the US and EU LIMS industries, such as ThermoFis...